🇺🇸 Amantadin in United States

238 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. General Physical Health Deterioration — 45 reports (18.91%)
  2. Fall — 38 reports (15.97%)
  3. Gait Disturbance — 24 reports (10.08%)
  4. Fatigue — 23 reports (9.66%)
  5. Pyrexia — 23 reports (9.66%)
  6. Parkinson^S Disease — 21 reports (8.82%)
  7. Death — 18 reports (7.56%)
  8. Akinesia — 17 reports (7.14%)
  9. Hyperkinesia — 15 reports (6.3%)
  10. Hypokinesia — 14 reports (5.88%)

Source database →

Other Neuroscience approved in United States

Frequently asked questions

Is Amantadin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Amantadin in United States?

Centre Hospitalier Universitaire de Nice is the originator. The local marketing authorisation holder may differ — check the official source linked above.